Fulvestrant in Treating Patients With Recurrent Prostate Cancer

NCT00217464 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Closed for futility

Conditions

Prostate Cancer

Interventions

DRUG: fulvestrant

Sponsor

Roswell Park Cancer Institute